INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
02/13/2026
Back to search
Official data from USPTO
THINC-IT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THINC-IT
ST13
US500000079213637Class
5, 9, 10, 42, 44
Filing
79213637
Registration
5516053
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
02/14/2026
Trademark type
Word
Nice classes
5, 9, 10, 42, 44
Filing date
01/31/2017
Registration date
07/17/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2025
Last transaction
02/14/2026
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Valby, DK
Examiner
BENMAMAN, ALICE
Current location
Historical data usage
Holders and representatives
Holders
H. Lundbeck A/S
H. Lundbeck A/S
Representatives
Maren C. Perry King & Spalding LLP
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases ingenerated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorderstrokedepressioncognitive impairmentmood disorderspsychosisanxietyepilepsysclerosisporphyriaHuntington's disease and disorderinsomniaParkinson's disease and disorderschizophreniabipolar disorder and diseaseADHDcancerpainalcoholism and chemical dependency; medical diagnostic agentsreagentspreparations and substances for medical purposes; pharmaceutical preparations for treatment of cognitive disorders and diseases
Class 9
Downloadable electronic publications in the nature of booksreportsbrochuresbookletsleafletsincluding patient information leafletsmagazinesjournalsteaching and educational material in the field of research and developmentscienceclinical studiestests and trialsdiagnosticmedicinepharmaceuticalsdisordersdiseasestreatment and prevention ; computer application software for mobile devicessoftware for providing information and interaction in the field research and developmentscienceclinical studiestests and trialsdiagnosticmedicinepharmaceuticalsdisordersdiseasestreatment and prevention
Class 10
Medical diagnostic apparatus and instruments for use in diagnosingmanagingmonitoringassessingcontrolling and examining symptomssigns and effects of Alzheimer's disorder and diseasestrokedepressioncognitive impairmentmood disorderspsychosisanxietyepilepsysclerosisporphyriaHuntington's disease and disorderinsomniaParkinson's disease and disorderschizophreniabipolar disorder and diseaseADHDcancerpainalcoholism and chemical dependency; injection devices for pharmaceuticalssyringes and needles for injections and medical purposes; integrated medical systemsmedical diagnostic imaging apparatus and software sold as a unit therewith for managingmeasuringcollectingstoringmonitoringassessingcontrolling and examining patient data and information captured by the medical system in web-based physicalpsychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosagemeasuring and monitoringdrug delivery devices and systems
Class 42
Pharmaceutical research and development; scientific and technological servicesresearch in the field of medical disordersdiseasestreatment and prevention; scientific and technological servicesresearch in the field of the central nervous system and central nervous system related disordersdiseases and pharmaceuticals; medical research and tests in the field of psychology and neurology; conducting clinical research and tests in the field of psychology and neurology; medical diagnostic research and tests namelyconducting clinical trials for others
Class 44
Medical servicestherapeutic services and healthcare servicesclinical healthcare services; providing medical and healthcare information; services in the field of psychiatry and psychology and medical treatment of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disordersdiseases and pharmaceuticals; providing medical and medicinal information in the field of diagnosticmedicinepharmaceuticalsdisordersdiseasestreatment and prevention; providing on-line medical data and analyses designed to provide patients and clients customized informationregarding calculation of medical dosediagnosistherapeutic issues and medical management
Publications
History of USPTO decisions and trademark events.
43 publications found
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/13/2025
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
06/13/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/13/2025
ES71
TEAS SECTION 71 RECEIVED
01/15/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/22/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/22/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/22/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/22/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/22/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/17/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/16/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/29/2018
FIMP
FINAL DISPOSITION PROCESSED
10/29/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/17/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
07/17/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/01/2018
PUBO
PUBLISHED FOR OPPOSITION
05/01/2018
GPNX
NOTIFICATION PROCESSED BY IB
04/27/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/11/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/11/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/11/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
03/26/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
03/23/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/20/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
03/20/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/20/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
03/20/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/20/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/23/2018
ALIE
ASSIGNED TO LIE
02/22/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2018
RFNT
REFUSAL PROCESSED BY IB
09/01/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/15/2017
RFRR
REFUSAL PROCESSED BY MPU
08/14/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/11/2017
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2017
CNRT
NON-FINAL ACTION WRITTEN
08/10/2017
DOCK
ASSIGNED TO EXAMINER
08/07/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/04/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/03/2017
Continuous trademark protection
Get notified about every new filing that threatens THINC-IT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.